New Guidelines for RSV Vaccination
In August, the FDA approved the first-ever RSV vaccine, known as Abrysvo, for use during pregnancy to protect newborns in their first six months after birth. The vaccine is designed to be administered as a single dose during 32-36 weeks of gestation during RSV season—typically September through January.
Read more